January 5, 2013 Tuberculosis Comorbidity with Communicable and Non-Communicable Diseases: Integrating Health Services and Control Efforts
Advances in Tuberculosis Diagnostics: The Xpert MTB/RIF Assay and Future Prospects for a Point-of-Care Test
C-Path, CDISC launch “breakthrough” tool for TB drug development A “breakthrough” tool that standardises reporting of research data in the development of drug regimens to combat tuber
Eliminating Tuberculosis and Tuberculosis-HIV Co-Disease in the 21st Century: Key Perspectives, Controversies, Unresolved Issues, and Needs
Opportunities and Challenges for Cost-Efficient Implementation of New Point-of-Care Diagnostics for HIV and Tuberculosis
